J&J: Arthritis Drug Has Blood Cancer Risk
88685
Johnson & Johnson  is warning doctors that patients taking its rheumatoid arthritis drug Remicade may have a higher risk of lymphoma, a blood cancer, the company said on Friday.
134047
ARTHRITIS sufferers have been told to keep taking the painkiller Celebrex despite the drug&#39;s manufacturer finding an increased risk of heart attack in users of the drug.
160849
ARTHRITIS sufferers were yesterday warned that a widely-used painkiller increases the risk of heart attack and strokes and were urged to contact their doctors.
462742
People who use the drug Remicade for rheumatoid arthritis may be at increased risk of a serious blood disorder, the US Food and Drug Administration warned.
132854
With the recent news of heart problems associated with drugs such as Vioxx, Celebrex and Bextra, people who suffer from the pain associated with arthritis have difficult choices to make.
15642
NEW YORK, December 21  - The US Food and Drug Administration (FDA) warned today against the long-term usage of another arthritis drug, naproxen, after studies revealed increased risks of cardiovascular events.
340758
THURSDAY, Aug. 31 (HealthDay News) -- Concerns that rheumatoid arthritis drugs called TNF blockers and related medications could cause cancer appear to be unfounded, a new study shows.
634320
WASHINGTON -- Preliminary results of a new study suggest that high doses of Celebrex, a popular arthritis drug, can dramatically increase a person&#39;s risk of heart attack.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
736825
NEW YORK - Johnson &amp; Johnson will send a letter to doctors next Monday warning them that patients taking its rheumatoid arthritis drug Remicade may have a higher risk of lymphoma, a blood cancer, than those not taking the drug, the company said on Friday.
277613
[India News]: New York, Dec 20 : America&#39;s multibillion dollar pharmaceutical industry has been shaken by reports that Pfizer&#39;s high-profile arthritis drug, Celebrex, is said to cause an increased risk of heart attack.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
547870
A panel of experts advising the Food and Drug Administration gave strong signals yesterday that it thinks the blockbuster anemia drug called erythropoietin is overused in cancer treatment and may, in fact, be shortening the lives of some patients who take it.
425457
People on anti-HIV drug Viracept are being warned batches of the drug may have been infected with cancer-causing chemicals.
541938
Merck & Co. faces a dual threat from health insurers and patients' lawyers, after a U.S. study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
6886
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with anemia drugs sold by Amgen Inc and Johnson & Johnson.
730552
Johnson &amp; Johnson added a new warning to the label for rheumatoid arthritis drug Remicade about blood disorders that sometimes were fatal, US regulators announced on Tuesday.